CDH13 and urinary bladder cancer: Results from 4 studies comparing a total of 169 high-grade patients and 284 low-grade patients showed that CDH13 methylation was significantly associated with high-grade bladder cancer (OR = 2.22, 95 % CI = 1.72–6.80, P < 0.001) (Fig. 5).